XML 10 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover Page - shares
 3 Months Ended
Mar. 31, 2023
Nov. 03, 2023
Cover [Abstract]    
Document Type 10-Q/A  
Amendment Flag true  
Document Period End Date Mar. 31, 2023  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q1  
Entity Registrant Name BLUE RIDGE BANKSHARES, INC.  
Entity Central Index Key 0000842717  
Current Fiscal Year End Date --12-31  
Entity File Number 001-39165  
Entity Incorporation, State or Country Code VA  
Entity Tax Identification Number 54-1838100  
Entity Address, Address Line One 1807 Seminole Trail  
Entity Address, City or Town Charlottesville  
Entity Address, State or Province VA  
Entity Address, Postal Zip Code 22901  
City Area Code 540  
Local Phone Number 743-6521  
Trading Symbol BRBS  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company false  
Title of 12(b) Security Common Stock, no par value  
Security Exchange Name NYSE  
Entity Common Stock, Shares Outstanding   19,192,471
Amendment Description Blue Ridge Bankshares, Inc. (the "Company") is filing this Amendment No. 1 to its Quarterly Report on Form 10-Q for the period ended March 31, 2023 (the "Form 10-Q/A") for the purpose of adjusting the timing of when certain loans were placed on nonaccrual, reserved for, and charged off, as explained in the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission ("SEC") on October 31, 2023. Specifically, the Audit Committee of the Company's Board of Directors, after consultation with the Company’s independent registered public accounting firm and the primary regulator of its wholly-owned bank subsidiary, Blue Ridge Bank, N.A., determined that certain specialty finance loans that, as previously disclosed, were placed on nonaccrual, reserved for, or charged off in the interim periods ended March 31, 2023 and June 30, 2023 should have been reported as nonaccrual, reserved for, or charged off in earlier periods. These certain specialty finance loans totaled $63.5 million as of March 31, 2023 and are being reported as nonaccrual (nonperforming) loans in the Company's financial statements for the period ended March 31, 2023 included in this Form 10-Q/A.  
Document Quarterly Report true  
Document Transition Report false